A physiologic role for testosterone in limiting estrogenic stimulation of the breast C Dimitrakakis, J Zhou, J Wang, A Belanger, F LaBrie, C Cheng, D Powell, ... Menopause 10 (4), 292-298, 2003 | 240 | 2003 |
Androgens and the breast C Dimitrakakis, C Bondy Breast cancer research 11, 1-9, 2009 | 208 | 2009 |
Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy C Dimitrakakis, RA Jones, A Liu, CA Bondy Menopause 11 (5), 531-535, 2004 | 179 | 2004 |
Androgens and mammary growth and neoplasia C Dimitrakakis, J Zhou, CA Bondy Fertility and Sterility 77, 26-33, 2002 | 127 | 2002 |
Cancer in pregnancy: disentangling treatment modalities F Zagouri, C Dimitrakakis, S Marinopoulos, A Tsigginou, MA Dimopoulos ESMO open 1 (3), e000016, 2016 | 126 | 2016 |
Breast tuberculosis: Diagnosis, management and treatment S Marinopoulos, D Lourantou, T Gatzionis, C Dimitrakakis, I Papaspyrou, ... International journal of surgery case reports 3 (11), 548-550, 2012 | 120 | 2012 |
The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions C Dimitrakakis, G Kymionis, E Diakomanolis, I Papaspyrou, A Rodolakis, ... Gynecologic oncology 77 (1), 129-136, 2000 | 120 | 2000 |
Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS) R Glaser, AE York, C Dimitrakakis Maturitas 68 (4), 355-361, 2011 | 107 | 2011 |
Testosterone therapy in women: Myths and misconceptions R Glaser, C Dimitrakakis Maturitas 74 (3), 230-234, 2013 | 95 | 2013 |
Taxanes for breast cancer during pregnancy: a systematic review F Zagouri, TN Sergentanis, D Chrysikos, C Dimitrakakis, A Tsigginou, ... Clinical Breast Cancer 13 (1), 16-23, 2013 | 94 | 2013 |
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer F Zagouri, Z Bago-Horvath, F Rössler, A Brandstetter, R Bartsch, ... British journal of cancer 108 (5), 1100-1105, 2013 | 91 | 2013 |
Testosterone and breast cancer prevention R Glaser, C Dimitrakakis Maturitas 82 (3), 291-295, 2015 | 79 | 2015 |
Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study RL Glaser, C Dimitrakakis Maturitas 76 (4), 342-349, 2013 | 75 | 2013 |
Soy isoflavones and breast cancer risk: a meta-analysis I Boutas, A Kontogeorgi, C Dimitrakakis, SN Kalantaridou in vivo 36 (2), 556-562, 2022 | 68 | 2022 |
Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? GD Kymionis, CE Dimitrakakis, MM Konstadoulakis, I Arzimanoglou, ... Journal of Surgical Research 99 (2), 161-168, 2001 | 68 | 2001 |
Testosterone pellet implants and migraine headaches: a pilot study R Glaser, C Dimitrakakis, N Trimble, V Martin Maturitas 71 (4), 385-388, 2012 | 61 | 2012 |
Absence of transplacental passage of the low molecular weight heparin enoxaparin C Dimitrakakis, P Papageorgiou, I Papageorgiou, A Antzaklis, ... Pathophysiology of Haemostasis and Thrombosis 30 (5), 243-248, 2000 | 56 | 2000 |
Challenges in managing breast cancer during pregnancy F Zagouri, T Psaltopoulou, C Dimitrakakis, R Bartsch, MA Dimopoulos Journal of thoracic disease 5 (Suppl 1), S62, 2013 | 54 | 2013 |
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30 OM Ginsburg, MR Akbari, Z Aziz, R Young, H Lynch, P Ghadirian, ... Familial cancer 8, 563-567, 2009 | 50 | 2009 |
HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case–control study F Zagouri, TN Sergentanis, M Gazouli, A Tsigginou, C Dimitrakakis, ... Molecular biology reports 39, 10873-10879, 2012 | 47 | 2012 |